Hasil Pencarian - Martin Felices

Perbaiki Hasil
  1. 1
    Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer

    Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer oleh Philippa R. Kennedy, Martin Felices, Jeffrey S. Miller

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Immunotherapeutic Development of a Tri-Specific NK Cell Engager Recognizing BCMA

    Immunotherapeutic Development of a Tri-Specific NK Cell Engager Recognizing BCMA oleh Felix Oh, Martin Felices, Behiye Kodal, Jeffrey S. Miller, Daniel A. Vallera

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Dinaciclib enhances natural killer cell cytotoxicity against acute myelogenous leukemia

    Dinaciclib enhances natural killer cell cytotoxicity against acute myelogenous leukemia oleh Hyun Don Yun, Dawn K. Schirm, Martin Felices, Jeffrey S. Miller, Craig E. Eckfeldt

    Diterbitkan 2019-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review

    Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review oleh Locke D. Uppendahl, Carly M. Dahl, Jeffrey S. Miller, Martin Felices, Melissa A. Geller

    Diterbitkan 2018-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Activation of ADAM17 by IL-15 Limits Human NK Cell Proliferation

    Activation of ADAM17 by IL-15 Limits Human NK Cell Proliferation oleh Hemant K. Mishra, Kate J. Dixon, Nabendu Pore, Martin Felices, Jeffrey S. Miller, Bruce Walcheck

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Therapeutic effect of TRC105 and decitabine combination in AML xenografts

    Therapeutic effect of TRC105 and decitabine combination in AML xenografts oleh June Baik, Martin Felices, Ashley Yingst, Charles P. Theuer, Michael R. Verneris, Jeffrey S. Miller, Rita Perlingeiro

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    470 Targeting Pan-Tumor Associated Antigen B7H3 via Combination of Tri-specific Killer Engager and Off-the-shelf NK Cell Therapy Enhances Specificity and Function Against a Broad Range of Solid Tumors

    470 Targeting Pan-Tumor Associated Antigen B7H3 via Combination of Tri-specific Killer Engager and Off-the-shelf NK Cell Therapy Enhances Specificity and Function Against a Broad R... oleh Joshua Walker, Nicholas Zorko, Behiye Kodal, Alexander Lenvik, Todd Lenvik, Daniel Vallera, Alejandro Garcia, Martin Felices

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    675 Oxygen concentration alters natural killer cell phenotype and function in the solid tumor microenvironment

    675 Oxygen concentration alters natural killer cell phenotype and function in the solid tumor microenvironment oleh Martin Felices, Upasana Sunil Arvindam, Phillipa Kennedy, Brianna Ettestad, Peter Hinderlie, Gwen Phung, James Lim, Jeff Miller

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion

    Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion oleh Jacob A. Myers, Dawn Schirm, Laura Bendzick, Rachel Hopps, Carly Selleck, Peter Hinderlie, Martin Felices, Jeffrey S. Miller

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    335 Towards an implantable replenishable delivery device for natural killer cell and Tri-specific killer engager antibodies to the intraperitoneal space to treat ovarian cancer

    335 Towards an implantable replenishable delivery device for natural killer cell and Tri-specific killer engager antibodies to the intraperitoneal space to treat ovarian cancer oleh Eimear Dolan, Jeffrey S Miller, Martin Felices, Melissa A Geller, Carly Selleck, Aoibhin Sheedy, Niamh Ward, Lesley Trask, Garry Duffy

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Trispecific killer engager CD16xIL15xCD33 potently induces NK cell activation and cytotoxicity against neoplastic mast cells

    Trispecific killer engager CD16xIL15xCD33 potently induces NK cell activation and cytotoxicity against neoplastic mast cells oleh Hyun Don Yun, Martin Felices, Daniel A. Vallera, Peter Hinderlie, Sarah Cooley, Michel Arock, Jason Gotlib, Celalettin Ustun, Jeffrey S. Miller

    Diterbitkan 2018-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    638 Hypoxia reprograms natural killer cells and impairs their therapeutic potential

    638 Hypoxia reprograms natural killer cells and impairs their therapeutic potential oleh Jeffrey Miller, Martin Felices, Upasana Sunil Arvindam, Brianna Ettestad, Peter Hinderlie, James Lim, Philippa Kennedy, Shee Kwan Phung, Quinlan Kile, Yunmin Li

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Fewer circulating natural killer cells 28 days after double cord blood transplantation predicts inferior survival and IL-15 response

    Fewer circulating natural killer cells 28 days after double cord blood transplantation predicts inferior survival and IL-15 response oleh Rachel J. Bergerson, Robin Williams, Hongbo Wang, Ryan Shanley, Gretchen Colbenson, Alyssa Kerber, Sarah Cooley, Julie M. Curtsinger, Martin Felices, Jeffrey S. Miller, Michael R. Verneris

    Diterbitkan 2016-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    365 Oxygen levels found in bone marrow (5%) provide an optimal niche for the differentiation of induced-pluripotent stem cell-derived NK cells for the treatment of AML

    365 Oxygen levels found in bone marrow (5%) provide an optimal niche for the differentiation of induced-pluripotent stem cell-derived NK cells for the treatment of AML oleh Jeffrey S Miller, Bahram Valamehr, Behiye Kodal, Martin Felices, Peter Hinderlie, Laura Bendzick, Carly Selleck, Philippa R Kennedy, Quinlan M Kile, Rhett L Waller, Marissa Kaufman

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity

    TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity oleh Jeffrey S Miller, Behiye Kodal, Martin Felices, Peter Hinderlie, Michael F Kaminski, Laura Bendzick, Rachel Hopps, Marissa Kauffman, Yvette Soignier, Joshua T Walker, Todd R Lenvik, Melissa A Geller

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    1180 Maximizing NK cell immunotherapy in prostate cancer via TriKEs

    1180 Maximizing NK cell immunotherapy in prostate cancer via TriKEs oleh Joshua Walker, Jeffrey S Miller, Nicholas Zorko, Martin Felices, Peter Hinderlie, Shee Kwan Phung, Laura Bendzick, Yvette Soignier, Madison Shackelford, Asha Bozicevich, Carly Selleck, Trygve Nelson, Philippa R Kennedy

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells

    Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells oleh Jeffrey S Miller, Martin Felices, Shee Kwan Phung, Anders W Matson, Sam Wang, Ryan R Friess, Bruce Walcheck, Kate J Dixon, Jianming Wu, Rob Hullsiek, Anders J Lindstedt, Tanya S Freedman, Emily N Truckenbrod

    Diterbitkan 2024-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS

    161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS oleh Dhifaf Sarhan, Ludwig Brandt, Martin Felices, Karolin Guldevall, Todd Lenvik, Peter Hinderlie, Julie Curtsinger, Erica Warlick, Stephen R. Spellman, Bruce R. Blazar, Daniel J. Weisdorf, Sarah Cooley, Daniel A. Vallera, Björn Önfelt, Jeffrey S. Miller

    Diterbitkan 2018-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    A tri-specific killer engager against mesothelin targets NK cells towards lung cancer

    A tri-specific killer engager against mesothelin targets NK cells towards lung cancer oleh Philippa R. Kennedy, Daniel A. Vallera, Brianna Ettestad, Caroline Hallstrom, Behiye Kodal, Deborah A. Todhunter, Laura Bendzick, Peter Hinderlie, Joshua T. Walker, Brittany Pulkrabek, Ira Pastan, Robert A. Kratzke, Naomi Fujioka, Jeffrey S. Miller, Martin Felices

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation

    Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation oleh Jianbo Yang, Qianjin Liao, Matthew Price, Branden Moriarity, Natalie Wolf, Martin Felices, Jeffrey S. Miller, Melissa A. Geller, Laura Bendzick, Rachel Hopps, Timothy K. Starr, Christine H. O'Connor, Sarah Tarullo, Andrew C. Nelson, Eva Turley, Jing Wang, James B. McCarthy

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: